A New Brazilian Device for Cervical Cancer Screening: Acceptability and Accuracy of Self-sampling

To evaluate the accuracy and patient acceptability toward self-sampling using a new device - SelfCervix® - for detecting HPV-DNA. A total of 73 women aged 25-65 who underwent regular cervical cancer screening from March to October 2016 were included. Women performed self-sampling followed by a phys...

Full description

Saved in:

Bibliographic Details
Published in:	Revista Brasileira de ginecologia e obstetrícia Vol. 45; no. 5; pp. 235 - 241
Main Authors:	Lichtenfels, Martina, Lorenzi, Noely Paula Cristina, Tacla, Maricy, Yokochi, Kaori, Frustockl, Flávia, Silva, Camila Alves, Silva, André Luiz da, Termini, Lara, Farias, Caroline Brunetto
Format:	Journal Article
Language:	English
Published:	Brazil Thieme Revinter Publicações Ltda 01-05-2023 Federação Brasileira das Sociedades de Ginecologia e Obstetrícia
Subjects:	Brazil cytology diagnostic screening programs early detection of cancer Early Detection of Cancer - methods Female human papillomavirus Humans Mass Screening OBSTETRICS & GYNECOLOGY Original Papillomaviridae Papillomavirus Infections - diagnosis Patient Acceptance of Health Care Self Care uterine cervical neoplasms Uterine Cervical Neoplasms - diagnosis Uterine Cervical Neoplasms - prevention & control Vaginal Smears Brazil Detecção precoce do câncer cytology diagnostic screening programs early detection of cancer uterine cervical neoplasms human papillomavirus Papiloma vírus humano Programas de rastreamento Neoplasias do colo de útero
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	To evaluate the accuracy and patient acceptability toward self-sampling using a new device - SelfCervix® - for detecting HPV-DNA. A total of 73 women aged 25-65 who underwent regular cervical cancer screening from March to October 2016 were included. Women performed self-sampling followed by a physician-sampling, and the samples were analyzed for HPV-DNA. After that, patients were surveyed about their acceptability of self-sampling. HPV-DNA detection rate of self-sampling presented high accuracy and was similar to physician-collection. Sixty-four (87.7%) patients answered the acceptability survey. Most patients (89%) considered the self-sampling comfortable, and 82.5% preferred self-sampling to physician-sampling. The reasons cited were time-saving and convenience. Fifty-one (79.7%) reported that they would recommend self-sampling. Self-sampling using the new Brazilian device SelfCervix® is not inferior in HPV-DNA detection rate compared with physician-collection, and patients are supportive of the method. Therefore, it might be an option to reach under-screened populations in Brazil.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	0100-7203 1806-9339 1806-9339
DOI:	10.1055/s-0043-1770134